Home/Filings/4/0001209191-23-026318
4//SEC Filing

Stewart Richard Alistair 4

Accession 0001209191-23-026318

CIK 0000949858other

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 5:51 PM ET

Size

11.0 KB

Accession

0001209191-23-026318

Insider Transaction Report

Form 4
Period: 2023-04-28
Stewart Richard Alistair
DirectorChieve Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-04-28+5,00030,751 total
  • Tax Payment

    Common Stock

    2023-04-28$8.29/sh2,250$18,65228,501 total
  • Exercise/Conversion

    Performance Restricted Stock Unit (PRSU)

    2023-04-285,0000 total
    Exp: 2025-01-26Common Stock (5,000 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    359
  • Common Stock

    (indirect: By Ricanto Limited)
    882
Footnotes (5)
  • [F1]Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II.
  • [F2]Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs.
  • [F3]The reporting holder is a principal owner of Ricanto Limited.
  • [F4]Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
  • [F5]Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone.

Issuer

ACHIEVE LIFE SCIENCES, INC.

CIK 0000949858

Entity typeother

Related Parties

1
  • filerCIK 0001713369

Filing Metadata

Form type
4
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 5:51 PM ET
Size
11.0 KB